ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1259

Adverse Childhood Experiences Are Associated with Patient-Reported Outcomes in Adolescents and Young Adults with Systemic Lupus

Tamar Rubinstein1, Avni Dave2, Terrence Calistro3, Kimberly Rapoza3, Shari Salzhauer Berkowitz3, Joyce Hui-Yuen4, Zanab Mian5, Emily Masi6 and Kathleen Kenney-Riley7, 1Albert Einstein College of Medicine, White Plains, NY, 2Albert Einstein College of Medicine, Bronx, NY, 3Mercy University, Dobbs Ferry, NY, 4Northwell Health, Cohen Children's Medical Center, Great Neck, NY, 5Cohen Children's Medical Center, Lake Success, NY, 6Cohen Children's Medical Center, Floral Park, NY, 7Albert Einstein College of Medicine, Port Chester, NY

Meeting: ACR Convergence 2024

Keywords: Patient reported outcomes, Pediatric rheumatology, psychosocial factors, Systemic lupus erythematosus (SLE), Trauma

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Pediatric Rheumatology – Clinical Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Adverse childhood experiences (ACEs), are major life stressors that occur before the age of 18 and include experiences of household dysfunction. Recently, prior trauma, including childhood trauma, was found to be associated with incident systemic lupus erythematosus (SLE). Our previous work showed that people with SLE in the Bronx were more likely to be affected by ACEs than people without SLE. To gain a better understanding of the relationship between ACEs and disease outcomes in youth with SLE, we investigated the relationship between ACE exposure and patient-reported outcomes in adolescents and young adults with SLE.

Methods: We performed a secondary data analysis of the baseline data from a longitudinal observational study of adolescents and young adults (AYA) with SLE. People with SLE, ages 12-21 were recruited from outpatient clinics at the Children’s Hospital at Montefiore and Northwell Health. Participants were emailed links to a REDCap survey to complete questionnaires remotely on patient-reported outcomes including, PEDS-QL quality of life measure, PROMIS-25 pediatric global health index, depression symptoms questionnaire (CES-D) and an ACE questionnaire. ACE scores were then calculated as a total count from 0-9 and then categorized as 0, 1, 2-3, and ≥4 ACEs to reflect prior literature that shows a threshold effect at 4 ACEs for many health-related outcomes. Data was originally collected between 9/2019-3/2023.

Results: Among 94 AYA with SLE included in the original study, 91 (97%) completed ACE questionnaires at baseline visits and were included in the analysis. Among those included, 58 (64%) reported any ACE exposure, 17 (19%) reported 1 ACE, 17 (19%) reported 2-3 ACEs, and 24 (26%) reported ≥4 ACEs. Patient global disease scores, CES-D scores, all Peds-QL (physical, emotional, social, school), and PROMIS subscales for physical function, anxiety, depression, fatigue, and peer relationships were significantly associated with categorical ACE scores, with higher ACE exposure associated with worse outcomes (see Table 1). PROMIS subscales for pain were not associated with ACE scores.

Conclusion: Higher ACE exposure is associated with worse patient-reported outcomes related to global disease scores, health-related quality of life and depression symptom severity scores in AYA with SLE. In future analyses we intend to investigate whether ACE scores are associated with worse outcome progression over time and whether they are associated with physician-reported SLE disease activity and severity measures. Further work needs to be done to see whether addressing stress around ACEs in youth with SLE can improve disease outcomes.

Supporting image 1

All scores shown are median (interquartile range) raw scores. In each scale higher scores denote worse symptoms or worse functioning, except for PROMIS peer subscales where higher scores denote better functioning.


Disclosures: T. Rubinstein: None; A. Dave: None; T. Calistro: None; K. Rapoza: None; S. Berkowitz: None; J. Hui-Yuen: None; Z. Mian: None; E. Masi: None; K. Kenney-Riley: None.

To cite this abstract in AMA style:

Rubinstein T, Dave A, Calistro T, Rapoza K, Berkowitz S, Hui-Yuen J, Mian Z, Masi E, Kenney-Riley K. Adverse Childhood Experiences Are Associated with Patient-Reported Outcomes in Adolescents and Young Adults with Systemic Lupus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/adverse-childhood-experiences-are-associated-with-patient-reported-outcomes-in-adolescents-and-young-adults-with-systemic-lupus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adverse-childhood-experiences-are-associated-with-patient-reported-outcomes-in-adolescents-and-young-adults-with-systemic-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology